Health Economic Modelling Bristol University Group (HEMBUG)
Our group is dedicated to using innovative approaches in health economics modelling. Our mission is to tackle important issues in healthcare through development of rigorous modelling methods and applications. We have particular interest in modelling for health technology assessment, methods for value of information analysis, evidence synthesis methods to populate economic models, use of real world and otherwise limited evidence in economic models, economic assessments in Low and Middle Income Countries, and the R programming language.
Projects
- Automated conversion of Excel models into R for the Reliable and Efficient Estimation of the Economic Value of medical Research (REEEVR) project
- Evaluating the cost-effectiveness of the BBV opt-out program in UK Emergency Departments
- Assessing the cost-effectiveness of HCV self-testing in Georgia, Malaysia, and Pakistan
- Clinical and cost effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model
HEMBUG members contribute to the:
Bristol Technology Assessment Group (Bristol TAG) which is commissioned by NIHR to produce reviews of healthcare technologies to support NICE guidance committees
Guidelines Technical Support Unit (TSU) which provides rapid response technical support and training to NICE guideline developers
Multi-parameter Evidence Synthesis (MPES) research group who develop methods for evidence synthesis with complex evidence structures for populating decision models
HEMBUG members also have strong links to the international R for Health Technology Assessment organisation.
Key Members
Dr Howard Thom (Lead)
Dr Asra Asgharzadehkamachali and Mr Ayman Sadek (Deputy leads)
Professor Nicky Welton (Adviser)